Cite

HARVARD Citation

    Colombel, J. et al. (2018). Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Alimentary pharmacology & therapeutics. 47 (2), pp. 219-228. [Online]. 
  
Back to record